Biocure Technology, Inc. 從事生物相似藥產品的研發與商業化。公司總部位於加拿大卑詩省溫哥華。公司於2008年3月27日上市。該公司專注於開發與推廣自有CAR-T細胞療法,目標適應症為慢性淋巴性白血病及實體腫瘤癌症。此外,公司亦正在開發用於癌症治療的生物相似藥技術。公司產品包括干擾素β、雷珠單抗和聚乙二醇非格司亭。
BICTF stock price ended at $0.01 on 星期三, after rising Infinity%
On the latest trading day May 14, 2025, the stock price of BICTF rose by Infinity%, climbing from $0.01 to $0.01. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.01 and a high of $0.01. Notably, trading volume dropped by 38.7K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 39.0K shares were traded, equating to a market value of approximately --.